Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
183 studies found for:    "Wilms tumor"
Show Display Options
Rank Status Study
21 Completed Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Conditions: Childhood Renal Cell Carcinoma;   Clear Cell Renal Cell Carcinoma;   Clear Cell Sarcoma of the Kidney;   Papillary Renal Cell Carcinoma;   Rhabdoid Tumor of the Kidney;   Stage I Renal Cell Cancer;   Stage I Renal Wilms Tumor;   Stage II Renal Cell Cancer;   Stage II Renal Wilms Tumor;   Stage III Renal Cell Cancer;   Stage III Renal Wilms Tumor;   Stage IV Renal Cell Cancer;   Stage IV Renal Wilms Tumor
Interventions: Drug: Doxorubicin Hydrochloride;   Drug: Irinotecan Hydrochloride;   Procedure: Conventional Surgery;   Drug: Cyclophosphamide;   Drug: Etoposide;   Drug: Carboplatin;   Biological: Dactinomycin;   Drug: Vincristine Sulfate;   Radiation: Radiation Therapy;   Other: Laboratory Biomarker Analysis
22 Completed Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases
Conditions: Adult Rhabdomyosarcoma;   Lung Metastases;   Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Previously Treated Childhood Rhabdomyosarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Wilms Tumor and Other Childhood Kidney Tumors;   Stage IV Adult Soft Tissue Sarcoma;   Stage IV Wilms Tumor;   Stage V Wilms Tumor;   Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Radiation: intensity-modulated radiation therapy
23 Completed Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia;   Minimal Residual Disease;   Wilms Tumor
24 Completed To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
Conditions: Sarcoma;   Neuroblastoma;   Wilms Tumor;   Leukemia;   Lymphoma;   Brain Tumors
Intervention: Drug: Marqibo
25 Withdrawn A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors
Conditions: Sarcoma;   Neuroblastoma;   Wilms Tumor;   Osteosarcoma;   Brain Tumor
Intervention: Drug: Pazopanib (GW786034)
26 Completed Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
Conditions: Peritoneal Neoplasms;   Retroperitoneal Neoplasms;   Gastrointestinal Neoplasms;   Adenocarcinoma;   Neuroblastoma;   Ovarian Neoplasms;   Sarcoma;   Adrenocortical Carcinoma;   Wilms Tumor;   Rhabdomyosarcoma;   Desmoplastic Small Round Cell Tumor
Interventions: Drug: CHPP of Cisplatin;   Procedure: Abdominal Surgery
27 Withdrawn RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia
Conditions: Lymphoma;   Brain Neoplasms;   Sarcoma;   Osteosarcoma;   Wilm's Tumor
Interventions: Drug: RO4929097;   Drug: Dexamethasone
28 Completed Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients
Conditions: Neuroblastoma;   Rhabdomyosarcoma;   Lymphoma;   Wilm's Tumor;   Ewing's Sarcoma
Intervention: Drug: Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594)
29 Completed Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
Conditions: WAGR Syndrome;   Wilm's Tumor;   Aniridia;   Urogenital Abnormalities;   Mental Retardation
30 Unknown  Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
Condition: Kidney Cancer
Interventions: Biological: dactinomycin;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
31 Completed Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Condition: Kidney Cancer
Interventions: Genetic: gene expression analysis;   Genetic: proteomic profiling;   Genetic: reverse transcriptase-polymerase chain reaction;   Genetic: western blotting;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: spectroscopy
32 Completed Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor
Conditions: Kidney Cancer;   Renal Failure
Interventions: Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Other: laboratory biomarker analysis
33 Completed Biomarkers in Urine Samples From Patients With Wilms Tumor
Condition: Kidney Cancer
Interventions: Genetic: proteomic profiling;   Other: enzyme-linked immunosorbent assay;   Other: laboratory biomarker analysis;   Other: medical chart review
34 Completed DNA Variations in the Gene in Young Patients With Wilms' Tumor
Condition: Kidney Cancer
Interventions: Genetic: molecular genetic technique;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis
35 Completed Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors
Condition: Kidney Cancer
Interventions: Genetic: DNA methylation analysis;   Genetic: gene expression analysis;   Genetic: loss of heterozygosity analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: laboratory biomarker analysis
36 Completed
Has Results
Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy
Conditions: Myelodysplastic Syndrome;   Acute Myeloid Leukemia (AML);   Chronic Myeloid Leukemia (CML)
Intervention: Drug: WT1 Peptide Vaccine
37 Completed Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Condition: Kidney Cancer
Interventions: Genetic: DNA analysis;   Genetic: nucleic acid amplification;   Other: diagnostic laboratory biomarker analysis;   Other: medical chart review
38 Unknown  Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney
Condition: Kidney Cancer
Interventions: Biological: dactinomycin;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: melphalan;   Drug: vincristine sulfate;   Procedure: autologous bone marrow transplantation;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
39 Unknown  Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor
Condition: Kidney Cancer
Interventions: Biological: dactinomycin;   Drug: vincristine sulfate;   Procedure: conventional surgery
40 Recruiting Understanding Communication in Healthcare to Achieve Trust (U-CHAT)
Conditions: Neuroblastoma;   Sarcoma;   Carcinoma;   Desmoplastic Small Round Cell Tumor;   Retinoblastoma;   Wilms Tumor;   Melanoma

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years